CVE-2019-10964

Medtronic MiniMed 508 and Paradigm Series Insulin Pumps Improper Access Control

Description

Medtronic MiniMed Insulin Pumps are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Remediation

Workaround:

  • Medtronic recommends U.S. patients who are currently using the affected products talk to their healthcare provider about changing to a newer model insulin pump with increased cybersecurity protection. Patients outside the U.S. will receive a notification letter with instructions based on the country where they live. Medtronic recommends all patients take the cybersecurity precautions indicated below. CYBERSECURITY PRECAUTIONS RECOMMENDED FOR ALL PATIENTS: * Maintain tight physical control of the pump and devices connected to the pump * Do not share pump serial number * Be attentive to pump notifications, alarms, and alerts * Immediately cancel any unintended boluses (a single dose of insulin administered all at once) * Do not connect to any third-party devices or use any software not authorized by Medtronic * Disconnect CareLink USB devices from computers when not being used to download data from the pump * Monitor blood glucose levels closely and act as appropriate * Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis, or suspect an insulin pump settings, or insulin delivery have changed unexpectedly Medtronic has released additional patient-focused information, at the following location: https://www.medtronic.com/security

Categories

7.1
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.55%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: Medtronic MiniMed 508 pump
Affected: Medtronic MiniMed Paradigm 511 pump
Affected: Medtronic MiniMed Paradigm 512/712 pumps
Affected: Medtronic MiniMed Paradigm 712E pump
Affected: Medtronic MiniMed Paradigm 515/715 pumps
Affected: Medtronic MiniMed Paradigm 522/722 pumps
Affected: Medtronic MiniMed Paradigm 522K/722K pumps
Affected: Medtronic MiniMed Paradigm 523/723 pumps
Affected: Medtronic MiniMed Paradigm 523K/723K pumps
Affected: Medtronic MiniMed Paradigm Veo 554/754 pumps
Affected: Medtronic MiniMed Paradigm Veo 554CM/754CM pumps
Published at:
Updated at:

References

Link Tags
https://global.medtronic.com/xg-en/product-security/security-bulletins/minimed-508-paradigm.html
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-178-01
http://www.securityfocus.com/bid/108926 third party advisory vdb entry
https://www.us-cert.gov/ics/advisories/icsma-19-178-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2019-10964?
CVE-2019-10964 has been scored as a high severity vulnerability.
How to fix CVE-2019-10964?
As a workaround for remediating CVE-2019-10964: Medtronic recommends U.S. patients who are currently using the affected products talk to their healthcare provider about changing to a newer model insulin pump with increased cybersecurity protection. Patients outside the U.S. will receive a notification letter with instructions based on the country where they live. Medtronic recommends all patients take the cybersecurity precautions indicated below. CYBERSECURITY PRECAUTIONS RECOMMENDED FOR ALL PATIENTS: * Maintain tight physical control of the pump and devices connected to the pump * Do not share pump serial number * Be attentive to pump notifications, alarms, and alerts * Immediately cancel any unintended boluses (a single dose of insulin administered all at once) * Do not connect to any third-party devices or use any software not authorized by Medtronic * Disconnect CareLink USB devices from computers when not being used to download data from the pump * Monitor blood glucose levels closely and act as appropriate * Get medical help immediately when experiencing symptoms of severe hypoglycemia or diabetic ketoacidosis, or suspect an insulin pump settings, or insulin delivery have changed unexpectedly Medtronic has released additional patient-focused information, at the following location: https://www.medtronic.com/security
Is CVE-2019-10964 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-10964 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-10964?
CVE-2019-10964 affects Medtronic MiniMed 508 pump, Medtronic MiniMed Paradigm 511 pump, Medtronic MiniMed Paradigm 512/712 pumps, Medtronic MiniMed Paradigm 712E pump, Medtronic MiniMed Paradigm 515/715 pumps, Medtronic MiniMed Paradigm 522/722 pumps, Medtronic MiniMed Paradigm 522K/722K pumps, Medtronic MiniMed Paradigm 523/723 pumps, Medtronic MiniMed Paradigm 523K/723K pumps, Medtronic MiniMed Paradigm Veo 554/754 pumps, Medtronic MiniMed Paradigm Veo 554CM/754CM pumps.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.